## CRM: Salesforce, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.13 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($249.58)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Salesforce Inc. $CRM Stock Holdings Lowered by Vega Investment Solutions**
- Source: MarketBeat | 20251208T130819 | Somewhat-Bullish | Relevance: 99%
- Vega Investment Solutions significantly reduced its stake in Salesforce by 35.3% in Q2, selling 9,996 shares and retaining 18,297 shares valued at $4.99 million. Insider activity was mixed, with a director buying shares and the CEO selling some, while analysts maintain a "Moderate Buy" rating with an average target price of $326.54 for CRM. The company reported strong Q results, beating EPS expectations.

**2. Salesforce (CRM) Reports Q3 2026 Results, Wall Street Bullish**
- Source: Insider Monkey | 20251209T170756 | Bullish | Relevance: 99%
-  Salesforce (CRM) reported its fiscal Q3 2026 results, showing an 8.63% year-over-year revenue growth to $10.26 billion, despite slightly missing revenue expectations. The company's EPS of $3.25, however, exceeded consensus, leading to a more than 5% stock surge and a bullish outlook from Wall Street analysts. Management also raised its full-year guidance, driven by strong performance in Agentforce and Data 360 ARR.

**3. Daiwa Securities Group Inc. Increases Stake in Salesforce Inc. $CRM**
- Source: MarketBeat | 20251209T102903 | Somewhat-Bullish | Relevance: 99%
-  Daiwa Securities Group Inc. has significantly increased its stake in Salesforce Inc. (NYSE:CRM) by 23.4% in the second quarter, bringing its total holdings to 277,804 shares valued at over $75 million. This move is part of a broader trend of institutional investors adjusting their positions in Salesforce, alongside insider trading activity including a director's acquisition and another insider's sale of shares. The CRM provider recently reported strong quarterly earnings and announced a quarterly dividend, while analysts maintain a "Moderate Buy" consensus rating for the stock.

**4. Temasek Holdings Private Ltd Invests $12.76 Million in Salesforce Inc. $CRM**
- Source: MarketBeat | 20251208T124102 | Bullish | Relevance: 98%
-  Temasek Holdings Private Ltd has acquired a new stake in Salesforce Inc. (NYSE:CRM), purchasing 46,773 shares valued at approximately $12.76 million during the second quarter. Other institutional investors have also adjusted their positions in Salesforce, and several analysts have recently updated their ratings and price targets for the company. Salesforce recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend payment.

**5. Lombard Odier Asset Management Switzerland SA Buys 2,294 Shares of Salesforce Inc. $CRM**
- Source: MarketBeat | 20251209T130752 | Somewhat-Bullish | Relevance: 98%
- Lombard Odier Asset Management Switzerland SA increased its stake in Salesforce Inc. (NYSE:CRM) by 5.2% in the second quarter, acquiring an additional 2,294 shares to own a total of 46,129 shares valued at $12.58 million. The article also details other institutional investor activity, Salesforce's financial performance, recent dividend announcement, and analyst ratings, alongside insider trading information.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 10)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Morgan Stanley | $398 | $405 | -2% |
| 2025-12-08 | Citigroup | $257 | $253 | +2% |
| 2025-12-05 | DA Davidson | $235 | $225 | +4% |
| 2025-12-04 | Truist Securiti | $380 | $400 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Morgan Stanley | main | Overweight |
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-05 | DA Davidson | main | Neutral |
| 2025-12-04 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 29 ($26.85M) |
| Sells | 30 ($1.57M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.8%)
- Blackrock Inc.: 8.7% (-0.5%)
- State Street Corpora: 5.3% (+0.3%)
- JPMORGAN CHASE & CO: 2.8% (+46.5%)
- Geode Capital Manage: 2.2% (+0.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 6 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.13 suggests fair value with growth premium. Quality metrics strong (margin 18%). Balance sheet: $2.2B free cash flow. Analyst sentiment negative (10 target cuts vs 6 raises). Insider buying signal ($26.9M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $251.5B |
| Beta | 1.25 |
| 52W Range | $221.96 - $367.09 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.13 |
| Forward P/E | 20.3 |
| Current P/E | 22.5 |
| YoY Growth | 10.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 2.7% to 7.5% (+4.8% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 88th percentile. MRS_5 at 1.8% confirms short-term momentum alignment. AM_20 at 10.1% shows strong absolute momentum above own 20MA. Outperforming sector by 6.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.17), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.48% (CS: 89) | Strong |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 4.17 | Bullish |
| vs SMA20 | 1.101x | Above |
| vs SMA50 | 1.079x | Above |
| vs SMA200 | 1.021x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $264.20
- **Stop Loss:** $249.58 (5.5% risk)
- **Target:** $293.44 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 82
- **Position Value:** $21,664.40
- **Portfolio %:** 21.66%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-02-25 (Est: $3.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.86 | $3.25 | +13.6% |
| 2025Q3 | $2.78 | $2.91 | +4.7% |
| 2025Q2 | $2.55 | $2.58 | +1.3% |
| 2025Q1 | $2.61 | $2.78 | +6.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*